Business Description
CTC Bio Inc
ISIN : KR7060590007
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.58 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.47 | |||||
Debt-to-EBITDA | -3.77 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.33 | |||||
Beneish M-Score | -3.24 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.1 | |||||
3-Year EBITDA Growth Rate | 23.9 | |||||
3-Year EPS without NRI Growth Rate | 16.2 | |||||
3-Year Book Growth Rate | -4.9 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.61 | |||||
9-Day RSI | 35.77 | |||||
14-Day RSI | 38.64 | |||||
6-1 Month Momentum % | -2.48 | |||||
12-1 Month Momentum % | -17.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.08 | |||||
Quick Ratio | 0.61 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 131.9 | |||||
Days Sales Outstanding | 60.71 | |||||
Days Payable | 25.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | 1.75 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 33.84 | |||||
Operating Margin % | -5.23 | |||||
Net Margin % | -12.09 | |||||
FCF Margin % | -0.01 | |||||
ROE % | -21.94 | |||||
ROA % | -10.2 | |||||
ROIC % | -4.72 | |||||
ROC (Joel Greenblatt) % | -17.46 | |||||
ROCE % | -15.31 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.2 | |||||
PB Ratio | 2.39 | |||||
Price-to-Tangible-Book | 2.81 | |||||
Price-to-Operating-Cash-Flow | 72.59 | |||||
EV-to-EBIT | -12.67 | |||||
EV-to-EBITDA | -20.74 | |||||
EV-to-Revenue | 1.3 | |||||
EV-to-FCF | -21449.12 | |||||
Price-to-Projected-FCF | 2.25 | |||||
Price-to-Median-PS-Value | 0.87 | |||||
Earnings Yield (Greenblatt) % | -7.89 | |||||
FCF Yield % | -0.01 | |||||
Forward Rate of Return (Yacktman) % | -33.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
CTC Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 138,949.316 | ||
EPS (TTM) (â‚©) | -702 | ||
Beta | 0.77 | ||
Volatility % | 26.01 | ||
14-Day RSI | 38.64 | ||
14-Day ATR (â‚©) | 360.119285 | ||
20-Day SMA (â‚©) | 7354 | ||
12-1 Month Momentum % | -17.11 | ||
52-Week Range (â‚©) | 6050 - 11730 | ||
Shares Outstanding (Mil) | 23.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
CTC Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
CTC Bio Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
CTC Bio Inc Frequently Asked Questions
What is CTC Bio Inc(XKRX:060590)'s stock price today?
When is next earnings date of CTC Bio Inc(XKRX:060590)?
Does CTC Bio Inc(XKRX:060590) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |